title: Investigating the effects of resveratrol on chronically ischemic myocardium in a swine model of metabolic syndrome: a proteomics analysis.
abstract: Resveratrol has been shown to improve cardiac perfusion and ventricular function after chronic ischemic injury. Using proteomic analysis, we sought to objectively investigate potential mechanisms, by which resveratrol exerts its cardioprotective effects in the setting of metabolic syndrome and chronic myocardial ischemia. Yorkshire swine were divided into two groups based on diet: high cholesterol (n=7) or a high-cholesterol diet with supplemental resveratrol (n=6). Four weeks later, all animals underwent surgical placement of an ameroid constrictor to their left circumflex artery. Diets were continued for another 7 weeks, and then the ischemic myocardium was harvested for proteomics analysis. Proteomic analysis identified 669 common proteins between the two groups. Of these proteins, 76 were statistically different, of which 41 were characterized (P<.05). Pathway analysis demonstrated that in animals supplemented with resveratrol, there was a downregulation in several proteins involved with mitochondrial dysfunction, cell death, and unfavorable cardiac remodeling. Furthermore, there was an upregulation in proteins involved in free radical elimination. We conclude that resveratrol supplementation significantly alters several critical protein markers in the chronically ischemic myocardium. Further investigation of these proteins may help elucidate the mechanisms by which resveratrol exerts its cardioprotective effects.
authors.affiliation: Division of Cardiothoracic Surgery, Cardiovascular Research Center, Warren Alpert School of Medicine, Brown University , Providence, Rhode Island, USA .
authors.forename: Ashraf A
authors.initials: AA
authors.lastname: Sabe
authors.forename: Ahmed A
authors.initials: AA
authors.lastname: Sadek
authors.forename: Nassrene Y
authors.initials: NY
authors.lastname: Elmadhun
authors.forename: Rahul S
authors.initials: RS
authors.lastname: Dalal
authors.forename: Michael P
authors.initials: MP
authors.lastname: Robich
authors.forename: Cesario
authors.initials: C
authors.lastname: Bianchi
authors.forename: Frank W
authors.initials: FW
authors.lastname: Sellke
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000378:metabolism; D015415:Biomarkers / Q000378:metabolism; D016923:Cell Death; D002791:Cholesterol, Dietary / Q000008:administration & dosage; D003331:Coronary Vessels; D019587:Dietary Supplements; D004195:Disease Models, Animal; D006321:Heart / Q000187:drug effects* / Q000503:physiopathology; D008297:Male; D024821:Metabolic Syndrome / Q000150:complications*; D008928:Mitochondria / Q000187:drug effects; D017202:Myocardial Ischemia / Q000150:complications / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D009206:Myocardium / Q000378:metabolism* / Q000473:pathology; D008517:Phytotherapy; D010936:Plant Extracts / Q000494:pharmacology* / Q000627:therapeutic use; D011506:Proteins / Q000378:metabolism*; D040901:Proteomics; D000077185:Resveratrol; D015398:Signal Transduction; D013267:Stilbenes / Q000494:pharmacology* / Q000627:therapeutic use; D013552:Swine
chemical_list: D000975:Antioxidants; D015415:Biomarkers; D002791:Cholesterol, Dietary; D010936:Plant Extracts; D011506:Proteins; D013267:Stilbenes; D000077185:Resveratrol
keywords: ischemic heart disease; metabolic syndrome; metabolism; proteomics; remodeling; resveratrol
references.citation: Circulation. 2010 Sep 14;122(11 Suppl):S142-9
references.pmid: 20837905
references.citation: Ann N Y Acad Sci. 2013 Jul;1290:130-5
references.pmid: 23855475
references.citation: Nat Rev Drug Discov. 2006 Jun;5(6):493-506
references.pmid: 16732220
references.citation: Biochemistry. 2002 Feb 26;41(8):2850-8
references.pmid: 11851433
references.citation: Eur J Pharmacol. 2011 Aug 16;664(1-3):45-53
references.pmid: 21575630
references.citation: Arch Surg. 2011 May;146(5):556-64
references.pmid: 21739664
references.citation: Exp Gerontol. 2006 Oct;41(10):952-6
references.pmid: 16962276
references.citation: Biol Reprod. 2011 Jun;84(6):1182-9
references.pmid: 21248284
references.citation: Cell Metab. 2012 May 2;15(5):675-90
references.pmid: 22560220
references.citation: Cancer Res. 2006 Aug 1;66(15):7615-20
references.pmid: 16885361
references.citation: Crit Care Med. 2012 Nov;40(11):3026-33
references.pmid: 22926332
references.citation: Biochemistry. 2000 Jun 13;39(23):6944-50
references.pmid: 10841776
references.citation: Curr Opin Cardiol. 2011 May;26(3):196-203
references.pmid: 21430528
references.citation: Circulation. 2001 Jan 2;103(1):65-71
references.pmid: 11136687
references.citation: J Surg Res. 2013 Aug;183(2):531-6
references.pmid: 23622724
references.citation: Curr Atheroscler Rep. 2011 Dec;13(6):439-46
references.pmid: 21870059
references.citation: Nature. 2006 Nov 16;444(7117):337-42
references.pmid: 17086191
references.citation: J Thorac Cardiovasc Surg. 2014 Feb;147(2):792-8; Discussion 798-9
references.pmid: 24267781
references.citation: Am J Pathol. 2013 Mar;182(3):701-13
references.pmid: 23274061